US 10716869
Radiolabeled macrocyclic EGFR inhibitor
granted A61KA61K51/0459A61P
Quick answer
US patent 10716869 (Radiolabeled macrocyclic EGFR inhibitor) held by Oncodesign SA expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Oncodesign SA
- Grant date
- Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K51/0459, A61P, A61P35/00